{"id":3157,"date":"2026-06-04T08:04:52","date_gmt":"2026-06-04T08:04:52","guid":{"rendered":"https:\/\/vacure-conference.net\/?page_id=3157"},"modified":"2026-06-04T08:26:58","modified_gmt":"2026-06-04T08:26:58","slug":"preliminary-program-vac-2027","status":"publish","type":"page","link":"https:\/\/vacure-conference.net\/index.php\/preliminary-program-vac-2027\/","title":{"rendered":"Preliminary program"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3157\" class=\"elementor elementor-3157\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9cb163b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9cb163b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a3fc5ec\" data-id=\"a3fc5ec\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ce423fe elementor-widget elementor-widget-heading\" data-id=\"ce423fe\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.6.5 - 27-04-2022 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">VAC 2027 PRELIMINARY program<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3a053a1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3a053a1\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1161937\" data-id=\"1161937\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e09e8d8 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"e09e8d8\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;none&quot;}\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a href=\"https:\/\/vacure-conference.net\/wp-content\/uploads\/2026\/06\/VAC2027-preliminary-program.pdf\" class=\"elementor-button-link elementor-button elementor-size-xs elementor-animation-shrink\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Download the preliminary program<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f906d20 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f906d20\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c193347\" data-id=\"c193347\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-50c20cc elementor-widget elementor-widget-text-editor\" data-id=\"50c20cc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.6.5 - 27-04-2022 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#818a91;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#818a91;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>Venue:\u00a0CosmoCaixa Barcelona (<a href=\"https:\/\/cosmocaixa.org\/es\/\" target=\"_blank\" rel=\"noopener\">https:\/\/cosmocaixa.org\/es\/<\/a>)\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4d1e520 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4d1e520\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0ed6466\" data-id=\"0ed6466\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3e37d4a elementor-widget elementor-widget-text-editor\" data-id=\"3e37d4a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt; line-height: 15.6933px; color: rgb(0, 0, 0); font-style: normal; font-weight: 400;\"><font face=\"Arial Nova Light, sans-serif\">&#8211;<\/font><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #6db52c;\"><b><span lang=\"EN-US\" style=\"font-size: 16pt; font-family: 'Arial Nova Light', sans-serif;\">DAY 1 \u2013 TUESDAY 9 MARCH 2027<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif; color: #222a35;\">12:00-13:00&nbsp; <b>Registration<\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Opening<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">13:00-13:10&nbsp; Welcome. Mariona Graupera, Chair of the Scientific Committee<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">13:10-13:20&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">Patient representatives\u2019 message<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">13:20-13:30&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">Patient testimonies<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Keynote Lecture I<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">13:30-14:15&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">Clinical Management of patients with vascular anomalies. <span style=\"color: #6db52c;\">Beth Drolet (USA)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 1 &#8211; Venous Malformations<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">14:15-14:40&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">TALK<\/span><\/b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">: New models for the study of venous malformations. <span style=\"color: #6db52c;\">Elisa Boscolo (USA)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">14:40-14:55&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 1<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">14:55-15:10&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 2<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt; line-height: 15.6933px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><a name=\"_Hlk221097867\"><\/a><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 17.12px; font-family: 'Arial Nova Light', sans-serif;\">15:10- 15:40 <b><span style=\"color: #6db52c;\">Coffee break<\/span><\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:40-16:05&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">TALK<\/span><\/b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">: Embryonic development errors driving venous malformations. <span style=\"color: #6db52c;\">Ana Angulo-Urarte (IJC, Spain)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:05-16:20&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 3<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:20-16:35&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 4<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:35-17:00&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">TALK<\/span><\/b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">: New genetic insights on venous malformations. <span style=\"color: #6db52c;\">Sarah Sheppard <\/span>&#8211;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:00-17:15&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 5<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:15-17:30&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">SHORT TALK 6<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:30-18:10&nbsp; <b>Flash Talks 1<\/b>: 6 short talks, 5 min each + 10min discussion<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 12pt 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Welcome Drink<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">18:10-19:30&nbsp; Networking drink<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #6db52c;\"><b><span lang=\"EN-US\" style=\"font-size: 16pt; font-family: 'Arial Nova Light', sans-serif;\">DAY 2 \u2013 WEDNESDAY 10 MARCH 2027<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Keynote Lecture II<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">13:30-14:15&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">\u2013 Genetic and environmental determinants on vascular anomalies <span style=\"color: #6db52c;\">Claire Shovlin<\/span><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\"><span style=\"color: #6db52c;\"><br><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 2 \u2013 Lymphatic Malformations &amp; Lymphedema<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">09:30-09:40&nbsp; <b>Patient Testimonies<\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">09:40-10:05&nbsp; <b>TALK<\/b>: Endothelial cell dynamics in lymphatic malformations. <span style=\"color: #6db52c;\">Taija Makinen (Finland)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">10:05-10:20&nbsp; SHORT TALK 7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">10:20-10:35&nbsp; SHORT TALK 8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">10:35-11:00&nbsp; <b>TALK:<\/b> Understanding complex lymphatic anomalies. <span style=\"color: #6db52c;\">Michael Dellinger<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 8pt; line-height: 15.6933px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 17.12px; font-family: 'Arial Nova Light', sans-serif;\">11:00-11:30<span style=\"color: #6db52c;\">&nbsp; <\/span><\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 17.12px; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Coffee break<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">11:30-11:55&nbsp; <b>TALK<\/b>: Treatments for kaposiform lymphangiomatosis. <span style=\"color: #6db52c;\">Shoshana Greenberger (Israel)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">11:55-12:10&nbsp; SHORT TALK 9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">12:10-12:25&nbsp; SHORT TALK 10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">12:25-13:25&nbsp; <b><span style=\"color: #6db52c;\">Lunch<\/span><\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">13:15-14:45&nbsp; <b>POSTER SESSION I<\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">14:45-15:00&nbsp; <b>Patient Testimonies<\/b>&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:00-15:25&nbsp; <b>TALK<\/b>: Clinical management of patients with congenital lymphedema. <span style=\"color: #6db52c;\">Isabelle Quere<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:25-15:40&nbsp; SHORT TALK 11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:40-15:55&nbsp; SHORT TALK 12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:55-16:35&nbsp; <b>Flash Talks<\/b> <b>2:<\/b> 6 short talks, 5 min each + 10min discussion&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:35-17:05&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Coffee break<\/span><\/b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\"> &nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:05-17:30&nbsp; <b>TALK<\/b>: Latest advances in lymphedema. <span style=\"color: #6db52c;\">Pia Ostergaard<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:30-17:45&nbsp; SHORT TALK 13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:45-18:00&nbsp; SHORT TALK 14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">18:00-18:30&nbsp; <b>ROUND TABLE:<\/b> Round table with patients, clinician and researcher<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Cultural activity<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">18:30-20:30&nbsp; Guided Walking Tour: Gothic Quarter and Born<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #6db52c;\"><b><span lang=\"EN-US\" style=\"font-size: 16pt; font-family: 'Arial Nova Light', sans-serif;\">DAY 3 \u2013 THURSDAY 11 MARCH 2027<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">08:00-08:45&nbsp; <b>MEET SPEAKERS:<\/b> Breakfast with the speakers<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Keynote Lecture III<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">08:45-09:30&nbsp; Novel iPSC models for the study of vascular diseases. <span style=\"color: #6db52c;\">Josef Penninger<\/span><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0cm; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\"><span style=\"color: #6db52c;\"><br><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 3 \u2013 Arteriovenous Malformations &amp; HHT<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">09:30-09:55&nbsp; <b>TALK<\/b>: Hemodynamic stress in arteriovenous malformations. <span style=\"color: #6db52c;\">Claudio Franco (Portugal)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">09:55-10:10&nbsp; SHORT TALK 15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">10:10-10:35&nbsp; <b>TALK<\/b>: The latest on BMP signalling in HHT. <span style=\"color: #6db52c;\">Sabine Bailly<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">10:35-11:05&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Coffee break<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">11:05-11:30&nbsp; <b>TALK<\/b>: How to approach therapeutic interventions in arteriovenous malformations. <span style=\"color: #6db52c;\">Julien Coulie<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">11:30-11:45&nbsp; SHORT TALK 16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">11:45-12:00&nbsp; SHORT TALK 17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">12:00-12:15&nbsp; <b>Patient Testimonies<\/b>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">12:15-13:15&nbsp; <b><span style=\"color: #6db52c;\">Lunch<\/span><\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">13:15-14:45&nbsp; <b>POSTER SESSION II<\/b><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\"><b><br><\/b><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 4 \u2013 Clinical Trials<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">14:45-15:10&nbsp; <b>TALK<\/b>: Clinical trials on PI3K-related syndromes <span style=\"color: #6db52c;\">Paloma Triana (Spain)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:10-15:25&nbsp; SHORT TALK 18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:25-15:40&nbsp; SHORT TALK 19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">15:40-16:10<span style=\"color: #6db52c;\">&nbsp; <\/span><\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Coffee break<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:10-16:35&nbsp; <b>TALK<\/b>&nbsp; \u2013 AKT inhibitors for management of patients with HHT. <span style=\"color: #6db52c;\">Antoni Riera-Mestre (Spain)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">16:35-17:00&nbsp; <b>TALK<\/b>: Molecular therapies for arteriovenous malformations. <span style=\"color: #6db52c;\">Laurence Boon (Belgium)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">17:00-17:15&nbsp; SHORT TALK 20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 12pt 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">VAC Dinner<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">20:00&nbsp; Dinner &amp; Networking<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: 16.8667px; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #6db52c;\"><b><span lang=\"EN-US\" style=\"font-size: 16pt; font-family: 'Arial Nova Light', sans-serif;\">DAY 4 \u2013 FRIDAY 12 MARCH 2027<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 5 &#8211; Capillary malformations<\/span><\/b><b><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">09:00-9:25&nbsp;&nbsp;&nbsp; <b>TALK<\/b>: Genotypes and phenotypes of capillary malformations. <span style=\"color: #6db52c;\">Eulalia Baselga (HSJD, Spain)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">09:25-09:40&nbsp; SHORT TALK 21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">09:40-09:55&nbsp; SHORT TALK 22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">09:55-10:10&nbsp; SHORT TALK 23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">10:10-10:35&nbsp; <b>TALK<\/b>: Cerebral capillary malformations caused by activating GNAQ signalling. <\/span><span lang=\"IT\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Ayal Ben-Zvi (Israel)<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">10:35-10:50&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">Patient Testimonies<\/span><\/b><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">10:50-11:20&nbsp; <\/span><b><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Coffee break<\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\"><br><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400; background: #acb9ca;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Session 6 &#8211; Cerebral Cavernous Malformations (CCM) &amp; Brain Lesions<\/span><\/b><b><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">11:20-11:45&nbsp; <b>TALK<\/b>: Novel therapeutic approaches for CCM. <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif; color: #6db52c;\">Michael Potente (Germany)<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">11:45-12:10&nbsp; <b>TALK:<\/b> Genetic basis of sporadic CCMs. <span style=\"color: #6db52c;\">Mark Khan (USA)<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">12:10-12:25&nbsp; SHORT TALK 24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selected from Abstracts<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">12:25-12:40&nbsp; SHORT TALK 25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selected from Abstracts<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">12:40-13:05&nbsp; <b>TALK<\/b>: The latest on cerebral small vessel diseases (SVD). <span style=\"color: #6db52c;\">Anne Joutel (France)<\/span><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\"><span style=\"color: #6db52c;\"><br><\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 6pt 0cm; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><b><span lang=\"EN-US\" style=\"font-size: 18pt; font-family: 'Arial Nova Light', sans-serif;\">Awards &amp; Closing<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 6pt; line-height: normal; font-size: 11pt; font-family: Calibri, sans-serif; color: #000000; font-style: normal; font-weight: 400;\"><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">13:05-13:15&nbsp; <\/span><span lang=\"EN-US\" style=\"font-size: 12pt; font-family: 'Arial Nova Light', sans-serif;\">Awards &amp; Closing<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>VAC 2027 PRELIMINARY program Download the preliminary program Venue:\u00a0CosmoCaixa Barcelona (https:\/\/cosmocaixa.org\/es\/)\u00a0 &#8211; DAY 1 \u2013 TUESDAY 9 MARCH 2027 12:00-13:00&nbsp; Registration Opening 13:00-13:10&nbsp; Welcome. Mariona Graupera, Chair of the Scientific Committee 13:10-13:20&nbsp; Patient representatives\u2019 message 13:20-13:30&nbsp; Patient testimonies Keynote Lecture I 13:30-14:15&nbsp; Clinical Management of patients with vascular anomalies. Beth Drolet (USA) &nbsp; Session 1 &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/vacure-conference.net\/index.php\/preliminary-program-vac-2027\/\"> <span class=\"screen-reader-text\">Preliminary program<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"class_list":["post-3157","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/3157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/comments?post=3157"}],"version-history":[{"count":39,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/3157\/revisions"}],"predecessor-version":[{"id":3202,"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/pages\/3157\/revisions\/3202"}],"wp:attachment":[{"href":"https:\/\/vacure-conference.net\/index.php\/wp-json\/wp\/v2\/media?parent=3157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}